Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma

衰老和青光眼中突触重塑和神经元自我修复的机制

基本信息

  • 批准号:
    9181431
  • 负责人:
  • 金额:
    $ 39.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-12-02 至 2019-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The long-term goal of this research is to elucidate how aging and intraocular pressure (IOP) influence retinal ganglion cell (RGC) degeneration in glaucoma and to leverage this knowledge to identify novel therapies based on neuronal protection, repair, and regeneration. This is an important goal, since all of vision is encoded by action potentials propagated along RGC axons in the optic projection. These axons degenerate steadily from adulthood to death and are susceptible early in glaucoma. Axonal signals are determined primarily by excitatory, glutamatergic synapses summed and integrated in the RGC dendritic arbor. The objective here is focused on understanding how RGC axon degeneration in the optic projection in aging and glaucoma relates to synapse degradation in the retina. To gain this understanding, experiments will test a novel central hypothesis: that early axonal stress due to aging and IOP induces self-repair and adaptive remodeling of the RGC synaptic complex to prolong signaling, similar to homeostatic plasticity of excitatory synapses in other systems. This dynamic relationship stands in stark contrast to the most prevalent current hypothesis in which early and irrevocable synaptic and dendritic pruning drives RGC axon loss. A series of rigorous, quantitative and functional assays will test this remodeling hypothesis by leveraging both chronic (DBA2J) and inducible (microbead occlusion) models of glaucoma. Experiments in Aim 1 will vary IOP and map changes in synaptic and cytoskeletal components to dendritic complexity and axonal function for different RGC types. Aim 2 will assess how synaptic and dendritic changes for RGC types characterized by axon function depend on age and whether aging influences the response to elevated IOP. Finally, Aim 3 will use established transgenic tools to modulate axonal and somatic degeneration and determine for key ages and IOPs whether dendrites and synapses in individual RGC types are conserved or undergo remodeling independently. These innovative studies combining neurochemical, morphological, and physiological measures will enrich the understanding of how synaptic and axonal activity interrelate at the molecular level and lay the foundation for novel therapeutics based on neuronal self-repair.
 描述(由申请人提供):本研究的长期目标是阐明衰老和眼内压(IOP)如何影响青光眼视网膜神经节细胞(RGC)变性,并利用这些知识来确定基于神经元保护、修复和再生的新疗法。这是一个重要的目标,因为所有的视觉都是由动作电位编码的,这些动作电位沿着沿着RGC轴突在视觉投射中传播。这些轴突从成年期到死亡期间稳定退化,并且在青光眼早期易受影响。轴突信号主要是由兴奋性的,神经元能突触总结和整合在RGC树突乔木。本研究的目的是了解老年人和青光眼视神经投射中的RGC轴突变性与视网膜中突触退化的关系。为了获得这种理解,实验将测试一个新的中心假设:由于老化和IOP导致的早期轴突应激诱导RGC突触复合体的自我修复和适应性重塑以延长信号传导,类似于其他系统中兴奋性突触的稳态可塑性。这种动态关系与当前最流行的假设形成鲜明对比,在该假设中,早期和不可撤销的突触和树突修剪驱动RGC轴突损失。一系列严格的、定量的和功能性的测定将通过利用青光眼的慢性(DBA2J)和诱导型(微珠阻塞)模型来测试这种重塑假设。目标1中的实验将改变IOP,并将突触和细胞骨架组分的变化映射到不同RGC类型的树突复杂性和轴突功能。目的2将评估以轴突功能为特征的RGC类型的突触和树突变化如何取决于年龄以及年龄是否影响对升高的IOP的反应。最后,Aim 3将使用已建立的转基因工具来调节轴突和体细胞变性,并确定关键年龄和IOP,单个RGC类型中的树突和突触是否是保守的或独立地进行重塑。这些结合神经化学、形态学和生理学措施的创新研究将丰富对突触和轴突活动如何在分子水平上相互关联的理解,并为基于神经元自我修复的新型疗法奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David J. Calkins其他文献

Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
青光眼神经退行性变的研究:机制、挑战与治疗
  • DOI:
    10.1016/j.preteyeres.2024.101261
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    14.700
  • 作者:
    Ghazi O. Bou Ghanem;Lauren K. Wareham;David J. Calkins
  • 通讯作者:
    David J. Calkins
M and L cones in macaque fovea connect to midget ganglion cells by different numbers of excitatory synapses
猕猴中央凹的 M 和 L 视锥细胞通过不同数量的兴奋性突触连接到侏儒神经节细胞
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling
  • 通讯作者:
    P. Sterling
OPTIC NERVE REGENERATION IN MAMMALS: REGENERATED OR SPARED
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David J. Calkins
  • 通讯作者:
    David J. Calkins
Ganglion cell circuits in primate fovea
灵长类动物中央凹的神经节细胞回路
  • DOI:
    10.1007/978-94-011-0507-1_32
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    13.7
  • 作者:
    David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling
  • 通讯作者:
    P. Sterling
High-resolution matrix-assisted laser desorption ionization–imaging mass spectrometry of lipids in rodent optic nerve tissue
啮齿动物视神经组织脂质的高分辨率基质辅助激光解吸电离成像质谱分析
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    David M. G. Anderson;Daniel Mills;J. Spraggins;W. Lambert;David J. Calkins;K. Schey
  • 通讯作者:
    K. Schey

David J. Calkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David J. Calkins', 18)}}的其他基金

Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
  • 批准号:
    10239017
  • 财政年份:
    2018
  • 资助金额:
    $ 39.5万
  • 项目类别:
Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
  • 批准号:
    10016302
  • 财政年份:
    2018
  • 资助金额:
    $ 39.5万
  • 项目类别:
Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma
适应性重塑机制及其在青光眼中的治疗潜力
  • 批准号:
    10583190
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
  • 项目类别:
Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma
衰老和青光眼中突触重塑和神经元自我修复的机制
  • 批准号:
    8976847
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
  • 项目类别:
Role of the Nrf2/ARE pathway in retinal ganglion cells during glaucoma pathogenesis and neuroprotection
Nrf2/ARE 通路在青光眼发病机制和神经保护中视网膜神经节细胞中的作用
  • 批准号:
    10291073
  • 财政年份:
    2012
  • 资助金额:
    $ 39.5万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    10231186
  • 财政年份:
    2012
  • 资助金额:
    $ 39.5万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    9982922
  • 财政年份:
    2012
  • 资助金额:
    $ 39.5万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    10414846
  • 财政年份:
    2012
  • 资助金额:
    $ 39.5万
  • 项目类别:
Transient Receptor Potential Channels and Neurodegeneration in Glaucoma
青光眼的瞬时受体电位通道和神经变性
  • 批准号:
    8708867
  • 财政年份:
    2008
  • 资助金额:
    $ 39.5万
  • 项目类别:
Transient Receptor Potential Channels and Retinal Ganglion Cell Death in Glaucoma
青光眼中的瞬时受体电位通道和视网膜神经节细胞死亡
  • 批准号:
    7870313
  • 财政年份:
    2008
  • 资助金额:
    $ 39.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了